Literature DB >> 8651119

Sequential assessment of exercise tolerance in heart transplantation compared with coronary artery bypass surgery after phase II cardiac rehabilitation.

H Daida1, R W Squires, T G Allison, B D Johnson, G T Gau.   

Abstract

To investigate the improvement in exercise capacity of transplant patients after an early postoperative (phase II) cardiac rehabilitation program during the first year after surgery, we analyzed retrospectively exercise capacity within 3 months (at the completion of phase II rehabilitation) and 1 year after surgery in 17 orthotopic heart transplantation patients (15 men and 2 women) and 17 age- and gender-matched coronary artery bypass graft (CABG) patients. All patients participated in a phase II cardiac rehabilitation exercise program followed by a home-based exercise program. At the completion of phase II cardiac rehabilitation, mean peak oxygen (VO2) adjusted for body weight in heart transplant patients was not significantly different from that in CABG patients (19.7 +/- 3.7 vs 21.9 +/- 4.1 ml/kg/min), and oxygen pulse at peak exercise did not differ between the 2 groups (11.5 +/- 2.5 vs 12.6 +/- 2.4 ml/beat). Between 3 months and 1 year after surgery, CABG patients had a marked increase in exercise time, increase in heart rate from rest to peak exercise (heart rate reserve), peak VO2, and oxygen pulse. In contrast, heart transplant patients had a significant but only modest increase in peak VO2, and were much more limited in exercise capacity at 1 year than were CABG patients (21.3 +/- 3.9 vs 27.4 +/- 4.7 ml/kg/min, p <0.0001). In our limited patient population, usual phase I rehabilitation with subsequent home-based exercise training was inadequate to improve the exercise capacity of heart transplant patients, and different rehabilitation protocols, such as long-term supervised exercise training, specific to this patient group may be indicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651119     DOI: 10.1016/s0002-9149(97)89202-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Exercise after heart transplantation.

Authors:  Claudio Marconi; Mauro Marzorati
Journal:  Eur J Appl Physiol       Date:  2003-09-06       Impact factor: 3.078

2.  Exercise-based cardiac rehabilitation for postcoronary artery bypass grafting and its effect on hemodynamic responses and functional capacity evaluated using the Incremental Shuttle Walking Test: A retrospective pilot analysis.

Authors:  Ahmad Osailan; Walid Kamal Abdelbasset
Journal:  J Saudi Heart Assoc       Date:  2020-04-17

3.  Improvements in exercise capacity following cardiac transplantation in a patient born with double inlet left ventricle.

Authors:  Steve Selig; Steve Foulkes; Mark Haykowsky
Journal:  BMJ Case Rep       Date:  2018-02-05

4.  Clinical features and determinants of VO2peak in de novo heart transplant recipients.

Authors:  Katrine Rolid; Arne K Andreassen; Marianne Yardley; Elisabeth Bjørkelund; Kristjan Karason; Julia P Wigh; Christian H Dall; Finn Gustafsson; Lars Gullestad; Kari Nytrøen
Journal:  World J Transplant       Date:  2018-09-10

5.  Pharmacological vs Exercise Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy.

Authors:  Milena A Gebska; Noah N Williford; Angela J Schadler; Carolyn Laxson; Paulino Alvarez; Alexandros Briasoulis; Linda M Cadaret; Ily Kristine T Yumul-Non; Richard E Kerber; Robert M Weiss
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-01-08

6.  Assessment of left ventricular performance in heart transplant recipients by three-dimensional speckle tracking imaging.

Authors:  Dan Wang; Li Zhang; Qingyu Zeng; Mingxing Xie
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817

7.  Clinical and Rehabilitative Predictors of Peak Oxygen Uptake Following Cardiac Transplantation.

Authors:  Katelyn E Uithoven; Joshua R Smith; Jose R Medina-Inojosa; Ray W Squires; Erik H Van Iterson; Thomas P Olson
Journal:  J Clin Med       Date:  2019-01-19       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.